ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 43

$2.29M Total Retail Price of All Prescriptions

Rank: 1 out of 43

834 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 16%.

Schedule Three
Controlled Substances

18% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 17,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 1,352 692 1 1
HYDROCODONE-ACETAMINOPHEN 1,076 756 S3 2 5
WARFARIN SODIUM 1,062 674 3 2
LISINOPRIL 879 583 4 3
SIMVASTATIN 846 427 5 6
FUROSEMIDE 806 534 6 4
METFORMIN HCL 692 309 7 12
OXYCODONE HCL 567 269 S2 8 15
GABAPENTIN 564 272 9 11
LACTULOSE 544 159 10 56
OLANZAPINE 529 308 11 36
OXYCODONE-ACETAMINOPHEN 516 265 S2 12 17
METOPROLOL TARTRATE 481 269 13 8
OMEPRAZOLE 477 199 14 7
RISPERIDONE 443 231 15 41
LANTUS 427 277 16 30
DIVALPROEX SODIUM 427 126 16 37
BENZTROPINE MESYLATE 423 201 R 18 80
TAMSULOSIN HCL 396 315 19 22
SERTRALINE HCL 392 178 20 25
LEVETIRACETAM 371 138 21 66
RANITIDINE HCL 347 140 22 39
FAMOTIDINE 342 154 23 51
FENTANYL 340 268 S2 24 31
CLOZAPINE 336 107 25 84
QUETIAPINE FUMARATE 320 191 26 26
CITALOPRAM HBR 302 195 27 10
POTASSIUM CHLORIDE 299 208 28 14
DIVALPROEX SODIUM ER 298 144 29 73
VENLAFAXINE HCL ER 296 71 30 44
HALOPERIDOL 295 150 31 79
ABILIFY 291 103 32 91
PAROXETINE HCL 290 166 33 38
GLIPIZIDE 288 209 34 35
ATENOLOL 284 184 35 16
BACLOFEN 280 102 36 63
TRAMADOL HCL 274 148 37 20
FENOFIBRATE 273 138 38 90
HYDROCHLOROTHIAZIDE 264 174 39 19
ATORVASTATIN CALCIUM 262 145 40 28
IPRATROPIUM-ALBUTEROL 258 104 41 53
GEMFIBROZIL 251 82 42 93
CYMBALTA 249 157 43 32
AMLODIPINE BESYLATE 237 156 44 9
MORPHINE SULFATE ER 235 139 S2 45 34
OXCARBAZEPINE 210 86 46 113
TRAZODONE HCL 205 131 47 47
MIRTAZAPINE 203 147 48 21
METHADONE HCL 200 71 S2 49 62
KLOR-CON M20 196 83 50 55
MORPHINE SULFATE 194 140 S2 51 74
ESCITALOPRAM OXALATE 192 101 52 46
ADVAIR DISKUS 191 100 53 49
GENERLAC 190 85 54 98
POLYETHYLENE GLYCOL 3350 182 106 55 42
DONEPEZIL HCL 181 139 56 13
LAMOTRIGINE 172 67 57 121
OXYCONTIN 171 97 S2 58 45
CARBAMAZEPINE 164 44 59 127
METOPROLOL SUCCINATE 163 124 60 23
ALBUTEROL SULFATE 162 65 61 78
ALENDRONATE SODIUM 159 114 62 18
SPIRIVA 152 81 63 54
PROPRANOLOL HCL 150 64 64 101
VALPROIC ACID 140 32 65 136
KLOR-CON 10 140 66 65 83
SEROQUEL 139 85 67 67
LEVOFLOXACIN 139 88 67 65
PREDNISONE 131 68 69 43
HUMALOG 131 101 69 102
PROAIR HFA 130 52 71 71
OXYBUTYNIN CHLORIDE 127 57 72 82
CARBIDOPA-LEVODOPA 126 121 73 50
SPIRONOLACTONE 126 67 73 59
OXYBUTYNIN CHLORIDE ER 126 43 73 86
NOVOLOG 124 86 76 99
LOVASTATIN 122 51 77 29
OLANZAPINE ODT 116 105 78 147
RISPERIDONE M-TAB 114 77 10 79 149
FLUOXETINE HCL 112 53 80 72
TIZANIDINE HCL 109 0 81 117
PHENYTOIN SODIUM EXTENDED 104 55 82 119
PANTOPRAZOLE SODIUM 102 62 83 61
ZIPRASIDONE HCL 99 26 84 154
LIDODERM 97 71 85 48
CEPHALEXIN 96 57 86 70
CARVEDILOL 93 79 87 40
ALLOPURINOL 93 79 87 52
LOSARTAN POTASSIUM 91 77 89 27
ROPINIROLE HCL 89 54 90 97
HALOPERIDOL DECANOATE 89 13 90 155
GLYBURIDE 88 14 R 92 94
FINASTERIDE 87 78 93 75
DOXAZOSIN MESYLATE 85 49 94 89
CIPROFLOXACIN HCL 85 50 94 64
LYRICA 83 49 96 58
AZITHROMYCIN 83 42 96 109
CLOPIDOGREL 79 51 98 57
CLONIDINE HCL 79 68 98 107
CYCLOBENZAPRINE HCL 73 20 R 100 140
NAMENDA 72 72 101 24
HYDROXYZINE HCL 71 57 R 102 165
FLUTICASONE PROPIONATE 70 39 103 60
NYSTATIN 70 49 103 87
PLAVIX 70 43 103 75
ZOLPIDEM TARTRATE 68 47 106 33
METHYLPHENIDATE HCL 67 0 107 137
PROCHLORPERAZINE MALEATE 67 28 107 169
LITHIUM CARBONATE 66 15 109 170
DILANTIN 65 28 110 173
TOPIRAMATE 64 19 111 174
VOLTAREN 62 34 112 106
CHLORTHALIDONE 61 29 113 176
VENLAFAXINE HCL 61 24 113 102
VENTOLIN HFA 60 27 115 179
COMBIVENT 57 34 116 128
IBUPROFEN 57 0 116 108
DIGOXIN 56 49 118 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 35 118 120
METOCLOPRAMIDE HCL 56 14 118 183
MUPIROCIN 55 43 121 186
ACTOS 53 30 122 191
DILTIAZEM 24HR CD 53 53 122 118
AMOXICILLIN 53 28 122 151
FAZACLO 52 0 125 193
TRIAMCINOLONE ACETONIDE 52 30 125 135
CHLORPROMAZINE HCL 50 0 127 197
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.